In a murine prostate cancer xenograft model, another near-infrared fluorescent dye conjugated with the MAO-A inhibitor isoniazid exhibited specific targeting of the tumor tissue and suppressed its growth, with good safety and no obvious treatment toxicity, as opposed to traditional chemotherapy [162]. The gene discussed is MAOA; the disease is prostate carcinoma.